Bioter S.A. (BIOT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bioter S.A. (BIOT) has a cash flow conversion efficiency ratio of 0.023x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-2.46 Million ≈ $-2.88 Million USD) by net assets (€-106.17 Million ≈ $-124.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Bioter S.A. market capitalisation for the company's overall valuation and market capitalisation.
Bioter S.A. - Cash Flow Conversion Efficiency Trend (2014–2022)
This chart illustrates how Bioter S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View BIOT live share price for real-time trading data and today's change.
Bioter S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bioter S.A. ranked by their cash flow conversion efficiency. Review financial flexibility index of Bioter S.A. to assess the company's free cash flow relative to its total liabilities.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fancy Wood Industries Public Company Limited
BK:FANCY
|
0.011x |
|
Pool Safe Inc
V:POOL
|
-3.557x |
|
Eterna Therapeutics Inc
NASDAQ:ERNA
|
-1.298x |
|
Bio-Gene Technology Ltd
AU:BGT
|
-0.811x |
|
Transatlantic Mining Corp
V:TCO
|
0.214x |
|
Odd Burger Corp
V:ODD
|
0.012x |
|
Aeeris Ltd
AU:AER
|
-0.227x |
|
H&T Group plc
LSE:HAT
|
0.033x |
Annual Cash Flow Conversion Efficiency for Bioter S.A. (2014–2022)
The table below shows the annual cash flow conversion efficiency of Bioter S.A. from 2014 to 2022. Also see Bioter S.A. total assets for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | €-106.17 Million ≈ $-124.12 Million |
€-9.46 Million ≈ $-11.06 Million |
0.089x | +34.82% |
| 2021-12-31 | €-96.49 Million ≈ $-112.81 Million |
€-6.38 Million ≈ $-7.45 Million |
0.066x | -36.34% |
| 2020-12-31 | €-87.69 Million ≈ $-102.52 Million |
€-9.10 Million ≈ $-10.64 Million |
0.104x | +51.53% |
| 2019-12-31 | €-93.64 Million ≈ $-109.48 Million |
€-6.41 Million ≈ $-7.50 Million |
0.068x | -17.40% |
| 2018-12-31 | €-85.02 Million ≈ $-99.39 Million |
€-7.05 Million ≈ $-8.24 Million |
0.083x | -57.38% |
| 2017-12-31 | €-71.39 Million ≈ $-83.47 Million |
€-13.89 Million ≈ $-16.24 Million |
0.195x | +47.08% |
| 2016-12-31 | €-54.16 Million ≈ $-63.32 Million |
€-7.16 Million ≈ $-8.38 Million |
0.132x | -46.53% |
| 2015-12-31 | €-35.44 Million ≈ $-41.43 Million |
€-8.77 Million ≈ $-10.25 Million |
0.247x | -34.62% |
| 2014-12-31 | €-25.33 Million ≈ $-29.61 Million |
€-9.58 Million ≈ $-11.20 Million |
0.378x | -- |
About Bioter S.A.
Bioter S.A. operates as a technical construction company in Greece and internationally. The company is involved in the execution of various projects, such as roads, ports, industrial-energy, electromechanical-communications, airports, war industries factories, etc., as well as private projects, such as offices, banks, bus stations, etc. The company was founded in 1961 and is based in Athens, Gree… Read more